As per Intent Market Research, the Cannabidiol Market was valued at USD 14.4 billion in 2024-e and will surpass USD 24.6 billion by 2030; growing at a CAGR of 9.3% during 2025 - 2030.
The cannabidiol (CBD) market has witnessed significant growth due to increasing consumer awareness regarding the therapeutic benefits of CBD, along with regulatory shifts favoring its commercialization. Rising acceptance of CBD-based products for medical and wellness applications, including pain management, anxiety relief, and skincare, has further fueled market expansion. The growing legalization of hemp-derived CBD across various regions has also played a crucial role in accelerating demand.
Technological advancements in extraction and formulation techniques have improved product quality and bioavailability, making CBD products more effective and appealing to consumers. Additionally, the expanding use of CBD in personal care, food and beverages, and pet care has widened market opportunities. With ongoing research into CBD's potential benefits and continued regulatory progress, the market is poised for sustained growth in the coming years.
CBD Oil Dominates the Product Segment Due to Its Versatile Applications
CBD oil holds the largest share in the cannabidiol market, owing to its broad applications across medical, wellness, and personal care industries. As a highly concentrated and easily customizable formulation, CBD oil is widely used in pain management, anxiety relief, sleep disorders, and skincare. The growing trend of self-care and natural wellness solutions has further boosted its popularity among consumers.
The increasing availability of CBD oil in various potency levels and formulations, including full-spectrum, broad-spectrum, and isolate-based options, has expanded its appeal. Additionally, the rise of sublingual CBD oil products and CBD tinctures has made consumption more convenient, driving market growth. As demand for natural and plant-based therapeutics continues to rise, CBD oil is expected to maintain its leading position.
.JPG)
Hemp-Derived CBD Leads the Market Due to Favorable Regulations and Higher Acceptance
Hemp-derived CBD dominates the market due to its widespread legality in multiple regions, particularly in North America and Europe. Since hemp-derived CBD contains minimal THC levels (below 0.3%), it is more widely accepted for both medical and wellness applications. This has led to an increased number of hemp-derived CBD-infused products in food, beverages, personal care, and pharmaceuticals.
The advancement of hemp cultivation and extraction technologies has further enhanced the purity and quality of hemp-derived CBD. Companies are focusing on organic and sustainable hemp farming to cater to health-conscious consumers. While marijuana-derived CBD is gaining traction in regions with legal recreational cannabis markets, hemp-derived CBD remains the preferred choice for mainstream consumer products.
Medical Use Holds the Largest Application Share Due to Increasing Therapeutic Adoption
The medical use segment accounts for the largest share in the CBD market, driven by growing acceptance of CBD in managing conditions such as chronic pain, epilepsy, anxiety, and inflammation. The FDA approval of Epidiolex (a CBD-based drug for epilepsy) has paved the way for increased research and development in pharmaceutical-grade CBD formulations.
Clinical studies highlighting CBD’s potential in treating neurological disorders, arthritis, and even certain mental health conditions have strengthened its position in the medical sector. Additionally, ongoing clinical trials exploring CBD’s role in cancer treatment, multiple sclerosis, and autoimmune diseases are expected to further expand its medical applications. As consumer interest in alternative and plant-based medicine continues to rise, the medical CBD segment will likely remain a key revenue driver.
Online Retail Leads the Distribution Channel Due to Convenience and Wide Product Availability
Online retail is the dominant distribution channel in the CBD market, as consumers prefer the convenience of ordering CBD products directly from brand websites and third-party e-commerce platforms. Online platforms offer a wider range of products, easy access to customer reviews, and discreet purchasing options, making them highly popular among CBD users.
The rise of digital marketing and direct-to-consumer (DTC) sales strategies has further strengthened online sales. Many CBD brands are leveraging social media, influencer marketing, and subscription models to boost consumer engagement and retention. Although brick-and-mortar stores, including pharmacies and specialty shops, play a crucial role in product availability, online retail remains the preferred channel due to its accessibility and competitive pricing.
North America Leads the Market Due to Favorable Regulations and High Consumer Awareness
North America holds the largest share in the cannabidiol market, primarily driven by the widespread legalization of hemp-derived CBD in the U.S. and Canada. The region's well-established CBD industry, coupled with high consumer awareness and spending power, has propelled market growth. The presence of major CBD brands and continuous product innovation have also contributed to North America's dominance.
The U.S. Farm Bill, which legalized industrial hemp cultivation, has significantly boosted the availability of hemp-derived CBD products. Additionally, the growing number of CBD-focused clinical studies and increasing acceptance among healthcare professionals have strengthened the market. As regulatory frameworks continue to evolve, North America is expected to maintain its leadership position in the global CBD industry.
.JPG)
Competitive Landscape and Key Players
The cannabidiol market is highly competitive, with key players including Charlotte’s Web, CBDistillery, Medterra, Canopy Growth, Elixinol, and Aurora Cannabis. These companies focus on product innovation, organic CBD formulations, and strategic partnerships to expand their market presence.
Mergers and acquisitions, collaborations with healthcare institutions, and investments in research and development are shaping the industry. Brands are also focusing on sustainable and transparent sourcing practices to appeal to eco-conscious consumers. With increasing competition, differentiation through quality, branding, and regulatory compliance will be essential for companies to gain a competitive edge in the cannabidiol market.
List of Leading Companies:
- Charlotte’s Web Holdings, Inc.
- Aurora Cannabis Inc.
- Canopy Growth Corporation
- CV Sciences, Inc.
- Medterra CBD
- Isodiol International Inc.
- GW Pharmaceuticals (Jazz Pharmaceuticals)
- Green Roads
- Elixinol Global Limited
- Endoca BV
- Bluebird Botanicals
- HempFusion Wellness Inc.
- NuLeaf Naturals
- Joy Organics
- cbdMD, Inc.
Recent Developments:
- In January 2025, Charlotte’s Web launched a new line of high-potency CBD oils for medical use.
- In December 2024, Canopy Growth introduced a THC-free CBD wellness beverage in the U.S. market.
- In November 2024, Aurora Cannabis expanded its product portfolio with a new range of CBD-infused skincare products.
- In October 2024, GW Pharmaceuticals received regulatory approval for its CBD-based epilepsy medication in multiple countries.
- In September 2024, Green Roads partnered with retail chains to expand its CBD distribution network across North America.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 14.4 billion |
|
Forecasted Value (2030) |
USD 24.6 billion |
|
CAGR (2025 – 2030) |
9.3% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Cannabidiol Market By Product Type (CBD Oil, CBD Isolates, CBD Capsules, CBD Edibles, CBD Topicals), By Source (Hemp-Derived CBD, Marijuana-Derived CBD, Synthetic CBD), By Application (Medical Use, Personal Care & Cosmetics, Food & Beverages, Pet Care), By Distribution Channel (Online Retail, Pharmacies, Specialty Stores) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
Charlotte’s Web Holdings, Inc., Aurora Cannabis Inc., Canopy Growth Corporation, CV Sciences, Inc., Medterra CBD, Isodiol International Inc., GW Pharmaceuticals (Jazz Pharmaceuticals), Green Roads, Elixinol Global Limited, Endoca BV, Bluebird Botanicals, HempFusion Wellness Inc., NuLeaf Naturals, Joy Organics, cbdMD, Inc. |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
Frequently Asked Questions
The Cannabidiol Market was valued at USD 14.4 billion in 2024-e and is expected to grow at a CAGR of over 9.3% from 2025 to 2030.
Increasing consumer awareness, expanding legalization, and rising demand for CBD in health and wellness.
Full-spectrum contains all hemp compounds, including trace THC, while broad-spectrum removes THC while keeping other cannabinoids.
CBD interacts with the endocannabinoid system to reduce inflammation and provide pain relief.
Pharmaceuticals, cosmetics, food & beverages, and pet care industries are major consumers of CBD.
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Cannabidiol Market, by Product Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. CBD Oil |
|
4.2. CBD Isolates |
|
4.3. CBD Capsules |
|
4.4. CBD Edibles |
|
4.5. CBD Topicals |
|
4.6. Others |
|
5. Cannabidiol Market, by Source (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Hemp-Derived CBD |
|
5.2. Marijuana-Derived CBD |
|
5.3. Synthetic CBD |
|
6. Cannabidiol Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Medical Use |
|
6.1.1. Pain Management |
|
6.1.2. Anxiety & Depression |
|
6.1.3. Epilepsy |
|
6.1.4. Others |
|
6.2. Personal Care & Cosmetics |
|
6.3. Food & Beverages |
|
6.4. Pet Care |
|
6.5. Others |
|
7. Cannabidiol Market, by Distribution Channel (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Online Retail |
|
7.2. Pharmacies |
|
7.3. Specialty Stores |
|
7.4. Others |
|
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America Cannabidiol Market, by Product Type |
|
8.2.7. North America Cannabidiol Market, by Source |
|
8.2.8. North America Cannabidiol Market, by Application |
|
8.2.9. North America Cannabidiol Market, by Distribution Channel |
|
8.2.10. By Country |
|
8.2.10.1. US |
|
8.2.10.1.1. US Cannabidiol Market, by Product Type |
|
8.2.10.1.2. US Cannabidiol Market, by Source |
|
8.2.10.1.3. US Cannabidiol Market, by Application |
|
8.2.10.1.4. US Cannabidiol Market, by Distribution Channel |
|
8.2.10.2. Canada |
|
8.2.10.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
8.3. Europe |
|
8.4. Asia-Pacific |
|
8.5. Latin America |
|
8.6. Middle East & Africa |
|
9. Competitive Landscape |
|
9.1. Overview of the Key Players |
|
9.2. Competitive Ecosystem |
|
9.2.1. Level of Fragmentation |
|
9.2.2. Market Consolidation |
|
9.2.3. Product Innovation |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10. Company Profiles |
|
10.1. Charlotte’s Web Holdings, Inc. |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2. Aurora Cannabis Inc. |
|
10.3. Canopy Growth Corporation |
|
10.4. CV Sciences, Inc. |
|
10.5. Medterra CBD |
|
10.6. Isodiol International Inc. |
|
10.7. GW Pharmaceuticals (Jazz Pharmaceuticals) |
|
10.8. Green Roads |
|
10.9. Elixinol Global Limited |
|
10.10. Endoca BV |
|
10.11. Bluebird Botanicals |
|
10.12. HempFusion Wellness Inc. |
|
10.13. NuLeaf Naturals |
|
10.14. Joy Organics |
|
10.15. cbdMD, Inc. |
|
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Cannabidiol Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Cannabidiol Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.png)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the Automated Breast Ultrasound Systems ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Cannabidiol Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.